{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T11:02:07Z","timestamp":1790938927199,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.transci.2007.12.001","type":"journal-article","created":{"date-parts":[[2008,2,9]],"date-time":"2008-02-09T12:52:04Z","timestamp":1202561524000},"page":"9-14","source":"Crossref","is-referenced-by-count":52,"title":["Expression of tissue factor pathway inhibitor by endothelial cells and platelets"],"prefix":"10.1016","volume":"38","author":[{"given":"Susan A.","family":"Maroney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan E.","family":"Mast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2007.12.001_bib1","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/338518a0","article-title":"Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor","volume":"338","author":"Girard","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.transci.2007.12.001_bib2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev.med.46.1.103","article-title":"Tissue factor pathway inhibitor and the revised theory of coagulation","volume":"46","author":"Broze","year":"1995","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.transci.2007.12.001_bib3","first-page":"159","article-title":"The role of tissue factor pathway inhibitor in a revised coagulation cascade","volume":"29","author":"Broze","year":"1992","journal-title":"Semin Hematol"},{"key":"10.1016\/j.transci.2007.12.001_bib4","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1055\/s-0038-1646439","article-title":"Inhibition of extrinsic pathway inhibitor shortens the coagulation time of normal plasma and of hemophilia plasma","volume":"66","author":"Nordfang","year":"1991","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.transci.2007.12.001_bib5","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0049-3848(91)90120-L","article-title":"Effect of lipoprotein-associated coagulation inhibitor (LACI) on thromboplastin-induced coagulation of normal and hemophiliac plasmas","volume":"64","author":"Welsch","year":"1991","journal-title":"Thromb Res"},{"key":"10.1016\/j.transci.2007.12.001_bib6","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/00001721-199507000-00004","article-title":"Blocking of tissue factor pathway inhibitor (TFPI) shortens the bleeding time in rabbits with antibody induced haemophilia A","volume":"6","author":"Erhardtsen","year":"1995","journal-title":"Blood Coagul Fibrinol"},{"key":"10.1016\/j.transci.2007.12.001_bib7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/(SICI)1096-8652(199903)60:3<175::AID-AJH1>3.0.CO;2-X","article-title":"Decreased plasma tissue factor pathway inhibitor in women taking combined oral contraceptives","volume":"60","author":"Harris","year":"1999","journal-title":"Am J Hematol"},{"key":"10.1016\/j.transci.2007.12.001_bib8","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1093\/humrep\/17.12.3235","article-title":"Effects of different progestin regimens in hormone replacement therapy on blood coagulation factor VII and tissue factor pathway inhibitor","volume":"17","author":"Bladbjerg","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.transci.2007.12.001_bib9","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1210\/jc.86.8.3629","article-title":"Prospective Randomized Study of Effects of Unopposed Estrogen Replacement Therapy on Markers of Coagulation and Inflammation in Postmenopausal Women","volume":"86","author":"Luyer","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.transci.2007.12.001_bib10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jsbmb.2004.12.026","article-title":"Differential effects of estrogens and progestins on the anticoagulant tissue factor pathway inhibitor in the rat","volume":"94","author":"Shirk","year":"2005","journal-title":"J Steroid Biochem Molecular Biol"},{"key":"10.1016\/j.transci.2007.12.001_bib11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1042\/CS20000324","article-title":"Effects of combined oral hormone replacement therapy on tissue factor pathway inhibitor and factor VII","volume":"101","author":"Peverill","year":"2001","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.transci.2007.12.001_bib12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1160\/TH04-11-0759","article-title":"Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study","volume":"94","author":"Wu","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.transci.2007.12.001_bib13","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.contraception.2005.08.011","article-title":"Does use of hormonal contraceptives among women with thrombogenic mutations increase their risk of venous thromboembolism? A systematic review","volume":"73","author":"Mohllajee","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.transci.2007.12.001_bib14","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1182\/blood.V90.3.944","article-title":"Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice","volume":"90","author":"Huang","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.transci.2007.12.001_bib15","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1182\/blood.V96.13.4222","article-title":"Spontaneous thrombosis in mice carrying the factor V Leiden mutation","volume":"96","author":"Cui","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.transci.2007.12.001_bib16","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1161\/01.CIR.0000017361.39256.82","article-title":"Lethal perinatal thrombosis in mice resulting from the interaction of tissue factor pathway inhibitor deficiency and factor V Leiden","volume":"105","author":"Eitzman","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.transci.2007.12.001_bib17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF02983209","article-title":"Clinical manifestations of paroxysmal nocturnal hemoglobinuria: present state and future problems","volume":"77","author":"Rosse","year":"2003","journal-title":"Int J Hematol"},{"key":"10.1016\/j.transci.2007.12.001_bib18","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1111\/j.1538-7836.2006.01873.x","article-title":"A GPI-anchored co-receptor for tissue factor pathway inhibitor controls its intracellular trafficking and cell surface expression","volume":"4","author":"Maroney","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.transci.2007.12.001_bib19","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1182\/blood-2002-10-3188","article-title":"Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis","volume":"101","author":"Dahm","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.transci.2007.12.001_bib20","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1161\/01.CIR.0000105900.21445.3D","article-title":"Involvement of tissue factor pathway inhibitor in the coronary circulation of patients with acute coronary syndromes","volume":"108","author":"Golino","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.transci.2007.12.001_bib21","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1161\/01.CIR.0000120705.55512.EC","article-title":"Endothelial cell markers and the risk of coronary heart disease: the prospective epidemiological study of myocardial infarction (PRIME) study","volume":"109","author":"Morange","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.transci.2007.12.001_bib22","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1160\/TH04-05-0293","article-title":"Total tissue factor pathway inhibitor is an independent risk factor for symptomatic paediatric venous thromboembolism and stroke","volume":"92","author":"Duering","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.transci.2007.12.001_bib23","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1055\/s-0037-1614443","article-title":"Low levels of heparin-releasable tissue factor pathway inhibitor in young patients with thrombosis","volume":"81","author":"Ariens","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.transci.2007.12.001_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00001721-200101000-00001","article-title":"Elevated levels of free tissue factor pathway inhibitor antigen in cases of disseminated intravascular coagulation caused by various underlying diseases","volume":"12","author":"Asakura","year":"2001","journal-title":"Blood Coagul Fibrinol"},{"key":"10.1016\/j.transci.2007.12.001_bib25","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/00001721-199701000-00012","article-title":"Elevated levels of tissue factor pathway inhibitor in acute non-lymphoblastic leukemia patients with disseminated intravascular coagulation","volume":"8","author":"Velasco","year":"1997","journal-title":"Blood Coagul Fibrinol"},{"key":"10.1016\/j.transci.2007.12.001_bib26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/jcan.2002.29677","article-title":"Tissue factor pathway inhibitor antigen and activity in 96 patients receiving heparin for cardiopulmonary bypass","volume":"16","author":"Adams","year":"2002","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.transci.2007.12.001_bib27","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1182\/blood.V78.2.387.387","article-title":"Plasma antigen levels of the lipoprotein-associated coagulation inhibitor in patient samples","volume":"78","author":"Novotny","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.transci.2007.12.001_bib28","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1538-7836.2005.01263.x","article-title":"The quest for the Holy Grail of tissue factor pathway inhibitor deficiency has just begun","volume":"3","author":"Ariens","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.transci.2007.12.001_bib29","doi-asserted-by":"crossref","first-page":"8869","DOI":"10.1073\/pnas.87.22.8869","article-title":"Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis","volume":"87","author":"Bajaj","year":"1990","journal-title":"PNAS"},{"key":"10.1016\/j.transci.2007.12.001_bib30","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1182\/blood.V79.12.3219.3219","article-title":"Expression of tissue factor pathway inhibitor by cultured endothelial cells in response to inflammatory mediators","volume":"79","author":"Ameri","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.transci.2007.12.001_bib31","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1182\/blood.V97.12.3721","article-title":"Regulation of monocyte procoagulant activity in acute myocardial infarction: role of tissue factor and tissue factor pathway inhibitor-1","volume":"97","author":"Ott","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.transci.2007.12.001_bib32","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1182\/blood.V72.6.2020.2020","article-title":"Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitor","volume":"72","author":"Novotny","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.transci.2007.12.001_bib33","first-page":"551","article-title":"Heterogeneity of plasma tissue factor pathway inhibitor","volume":"5","author":"Broze","year":"1994","journal-title":"Blood Coagul Fibrinol"},{"key":"10.1016\/j.transci.2007.12.001_bib34","doi-asserted-by":"crossref","first-page":"18832","DOI":"10.1016\/S0021-9258(18)51542-8","article-title":"Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma","volume":"264","author":"Novotny","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1016\/j.transci.2007.12.001_bib35","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1083\/jcb.133.2.293","article-title":"Ligand-induced protease receptor translocation into caveolae: a mechanism for regulating cell surface proteolysis of the tissue factor-dependent coagulation pathway","volume":"133","author":"Sevinsky","year":"1996","journal-title":"J Cell Biol"},{"key":"10.1016\/j.transci.2007.12.001_bib36","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/01.ATV.20.3.874","article-title":"Reversible regulation of tissue factor-induced coagulation by glycosyl phosphatidylinositol-anchored tissue factor pathway inhibitor","volume":"20","author":"Ott","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.transci.2007.12.001_bib37","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1161\/01.ATV.17.11.2964","article-title":"Tissue factor pathway inhibitor in endothelial cells colocalizes with glycolipid microdomains\/caveolae. Regulatory mechanism(s) of the anticoagulant properties of the endothelium","volume":"17","author":"Lupu","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.transci.2007.12.001_bib38","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0049-3848(88)90340-4","article-title":"Heparin induces release of extrinsic coagulation pathway inhibitor (EPI)","volume":"50","author":"Sandset","year":"1988","journal-title":"Thromb Res"},{"key":"10.1016\/j.transci.2007.12.001_bib39","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1161\/01.ATV.0000042456.84190.F0","article-title":"Characterization of the association of tissue factor pathway inhibitor with human placenta","volume":"22","author":"Mast","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.transci.2007.12.001_bib40","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1055\/s-0037-1614416","article-title":"TFPIbeta, a second product from the mouse tissue factor pathway inhibitor (TFPI) gene","volume":"81","author":"Chang","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.transci.2007.12.001_bib41","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1161\/01.CIR.0000078642.45127.7B","article-title":"Glycosyl phosphatidylinositol anchorage of tissue factor pathway inhibitor","volume":"108","author":"Zhang","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.transci.2007.12.001_bib42","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1146\/annurev.bi.62.070193.001005","article-title":"The structure and biosynthesis of glycosyl phosphatidylinositol protein anchors","volume":"62","author":"Englund","year":"1993","journal-title":"Annu Rev Biochem"},{"issue":"Pt 2","key":"10.1016\/j.transci.2007.12.001_bib43","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1042\/bj3270577","article-title":"Glypican-3 is a binding protein on the HepG2 cell surface for tissue factor pathway inhibitor","volume":"327","author":"Mast","year":"1997","journal-title":"Biochem J"},{"key":"10.1016\/j.transci.2007.12.001_bib44","doi-asserted-by":"crossref","first-page":"9201","DOI":"10.1073\/pnas.92.20.9201","article-title":"Fc{varepsilon}RI-mediated recruitment of p53\/56lyn to detergent-resistant membrane domains accompanies cellular signaling","volume":"92","author":"Field","year":"1995","journal-title":"PNAS"},{"key":"10.1016\/j.transci.2007.12.001_bib45","doi-asserted-by":"crossref","first-page":"11728","DOI":"10.1073\/pnas.91.24.11728","article-title":"Signal transduction of a G protein-coupled receptor in caveolae: colocalization of endothelin and its receptor with caveolin","volume":"91","author":"Chun","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.transci.2007.12.001_bib46","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1073\/pnas.96.5.2311","article-title":"Blood-borne tissue factor: another view of thrombosis","volume":"96","author":"Giesen","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.transci.2007.12.001_bib47","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1182\/blood-2004-03-0935","article-title":"Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation","volume":"104","author":"Chou","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.transci.2007.12.001_bib48","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/10739680590925682","article-title":"Interactions of platelets, blood-borne tissue factor, and fibrin during arteriolar thrombus formation in vivo","volume":"12","author":"Sim","year":"2005","journal-title":"Microcirculation"},{"key":"10.1016\/j.transci.2007.12.001_bib49","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1182\/blood.V95.5.1694.005k24_1694_1702","article-title":"Surface expression and functional characterization of alpha-granule factor V in human platelets: effects of ionophore A23187, thrombin, collagen, and convulxin","volume":"95","author":"Alberio","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.transci.2007.12.001_bib50","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/415175a","article-title":"Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface","volume":"415","author":"Dale","year":"2002","journal-title":"Nature"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050207001759?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050207001759?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T02:47:36Z","timestamp":1630723656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050207001759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S1473050207001759"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2007.12.001","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}